Abnormal Enchondral Ossification C4025628
Impaired bone formation from cartilage during development. Often seen in skeletal disorders and may affect bone growth and structure.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Restrictive Lung Disease
Reduced lung capacity due to chest wall deformities affecting respiratory function.
Seek immediate care for shortness of breath, chest pain, or difficulty breathing.
Spinal Cord Compression
Compression of spinal nerves or cord due to severe vertebral deformities, causing numbness or weakness.
Seek immediate care for sudden weakness, numbness, or loss of bladder/bowel control.
Skeletal Deformity
(musculoskeletal)Abnormal curvature or malformation of bones, commonly affecting the limbs or spine due to improper bone development.
Frequency: 80-90% of patients
Short Stature
(constitutional)Reduced height compared to peers due to impaired growth of long bones during development.
Frequency: 75-85% of patients
Joint Pain
(musculoskeletal)Persistent pain in joints, particularly weight-bearing joints like knees and hips, due to abnormal cartilage development.
Frequency: 60-70% of patients
Limited Joint Mobility
(musculoskeletal)Reduced range of motion in joints due to structural abnormalities and early joint degeneration.
Frequency: 50-60% of patients
Bone Pain
(musculoskeletal)Deep bone pain, often worse at night or with weight-bearing activities, caused by abnormal bone structure.
Frequency: 50-65% of patients
Premature Osteoarthritis
(musculoskeletal)Early-onset degenerative joint disease resulting from abnormal joint structure and cartilage integrity.
Frequency: 40-55% of patients
Increased Fracture Risk
(musculoskeletal)Bones are more susceptible to fractures due to structural weakness from abnormal ossification.
Frequency: 35-45% of patients
Scoliosis
(musculoskeletal)Lateral curvature of the spine that may develop due to asymmetric bone growth and vertebral abnormalities.
Frequency: 15-25% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Growth and Skeletal Development Monitoring
Regular assessment of bone growth, skeletal maturity, and height velocity through radiographs and physical examination. Monitoring allows for early identification of abnormalities and intervention timing.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Nutritional Support and Supplementation
Calcium, vitamin D, and phosphate supplementation along with balanced nutrition to support proper bone formation. Adequate micronutrient intake is essential for normal enchondral ossification processes.
Additional treatment options
Corrective Orthopedic Surgery
Surgical intervention to correct skeletal deformities, limb length discrepancies, or structural abnormalities resulting from abnormal enchondral ossification. Procedures may include osteotomies, lengthening, or fusion.
surgicalMobility and Strength Rehabilitation
Targeted physical therapy to maintain joint mobility, prevent contractures, and build supporting muscle strength. Therapeutic exercise supports bone loading necessary for healthy skeletal development.
physical_therapyPharmacological Management of Underlying Conditions
Treatment of primary conditions affecting bone metabolism such as vitamin D deficiency, hypothyroidism, or genetic disorders impacting ossification. Disease-specific medications address root causes.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Enchondral Ossification C4025628?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
American College of Medical Genetics and Genomics. Clinical practice guideline: skeletal dysplasias. Genetics in Medicine. 2020.
Warman ML, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2010 revision. American Journal of Medical Genetics Part A. 2011.
Klag KA, Horton WA. Advances in treatment of achondroplasia and osteoarthritis. Human Molecular Genetics. 2016.
Savarirayan R, Irving M, Maeda Y, et al. Effect of vosoritide on height in achondroplasia: a randomized, double-blind, placebo-controlled, phase 3 trial. The Lancet. 2020.
Wallace SE, Krakow D. Achondroplasia: manifestation and treatment. Current Osteoporosis Reports. 2019.
International Skeletal Dysplasia Society. Nosology and classification of genetic skeletal disorders 2019 revision. American Journal of Medical Genetics Part A. 2019.
Ornitz DM, Legey-Meurani C. Regulation of skeletal growth and osteogenesis by fibroblast growth factors. Nature Reviews Endocrinology. 2012.
Horton WA, Lunstrum GP. Fibroblast growth factor receptor 3 mutations in achondroplasia and related disorders. In: Rimoin DL, Pyeritz RE, Korf B, eds. Emery and Rimoin's Principles and Practice of Medical Genetics. 6th ed. Elsevier; 2013.
Ho H, Goto K, Sawada Y, et al. Long-term safety and efficacy of vosoritide in children with achondroplasia: 2-year results from a phase 3 trial. The Lancet Diabetes & Endocrinology. 2022.
Pauli RM. Achondroplasia: a comprehensive clinical review. Orphanet Journal of Rare Diseases. 2019.
Medication Comparisons
Compare medications used to treat Abnormal Enchondral Ossification C4025628. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy